SREEDEVI DAGGUBATI, MD
Hematology & Oncology Physician · SAN ANTONIO, TX
Individual Active NPI 1952373656
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 1,118 | 413,276 | $31,165,286 | $7,475,793 | $5,972,147 |
| 2023 | 1,101 | 405,861 | $28,379,139 | $6,699,530 | $5,342,265 |
| 2022 | 1,121 | 401,669 | $25,833,312 | $6,174,859 | $4,944,276 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J9025 | Injection, azacitidine, 1 mg | 40,900 | $0 | $0 |
| J1453 | Injection, fosaprepitant, 1 mg | 39,600 | $0 | $0 |
| J9263 | Injection, oxaliplatin, 0.5 mg | 36,200 | $0 | $0 |
| J9271 | Injection, pembrolizumab, 1 mg | 34,600 | $56 | $45 |
| J1756 | Injection, iron sucrose, 1 mg | 26,100 | $0 | $0 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 13,316 | $0 | $0 |
| J0881 | Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 12,795 | $3 | $2 |
| J1568 | Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg | 10,220 | $44 | $35 |
| J9267 | Injection, paclitaxel, 1 mg | 7,326 | $0 | $0 |
| J9171 | Injection, docetaxel, 1 mg | 6,384 | $1 | $1 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 6,199 | $0 | $0 |
| J0897 | Injection, denosumab, 1 mg | 5,100 | $25 | $20 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Hematology & Oncology Physician | 207RH0003X | ✓ | L1554 | TX |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- Yes
Other Hematology & Oncology Physician providers in Texas
- NPI 1700980299
- NPI 1629215850
- NPI 1538291380
- NPI 1881711133
- NPI 1336533512
- NPI 1376984807
- NPI 1609014695
- NPI 1255375531
See all Hematology & Oncology Physician providers in Texas →
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.